ARGENX SE - ADR (ARGX) Stock Fundamental Analysis

NASDAQ:ARGX • US04016X1019

821.96 USD
-11.58 (-1.39%)
At close: Feb 13, 2026
821.96 USD
0 (0%)
After Hours: 2/13/2026, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ARGX. ARGX was compared to 523 industry peers in the Biotechnology industry. ARGX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ARGX is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make ARGX a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year ARGX was profitable.
  • ARGX had a positive operating cash flow in the past year.
  • In the past 5 years ARGX reported 4 times negative net income.
  • ARGX had a negative operating cash flow in each of the past 5 years.
ARGX Yearly Net Income VS EBIT VS OCF VS FCFARGX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 17.84%, ARGX belongs to the top of the industry, outperforming 96.37% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 21.00%, ARGX belongs to the top of the industry, outperforming 95.98% of the companies in the same industry.
  • ARGX has a Return On Invested Capital of 6.01%. This is amongst the best in the industry. ARGX outperforms 91.97% of its industry peers.
Industry RankSector Rank
ROA 17.84%
ROE 21%
ROIC 6.01%
ROA(3y)-5.23%
ROA(5y)-11.34%
ROE(3y)-5.76%
ROE(5y)-13.95%
ROIC(3y)N/A
ROIC(5y)N/A
ARGX Yearly ROA, ROE, ROICARGX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

  • With an excellent Profit Margin value of 41.97%, ARGX belongs to the best of the industry, outperforming 97.51% of the companies in the same industry.
  • ARGX's Operating Margin of 15.30% is amongst the best of the industry. ARGX outperforms 93.12% of its industry peers.
  • With an excellent Gross Margin value of 89.40%, ARGX belongs to the best of the industry, outperforming 91.78% of the companies in the same industry.
Industry RankSector Rank
OM 15.3%
PM (TTM) 41.97%
GM 89.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARGX Yearly Profit, Operating, Gross MarginsARGX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • ARGX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for ARGX has been increased compared to 1 year ago.
  • ARGX has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ARGX is higher compared to a year ago.
ARGX Yearly Shares OutstandingARGX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ARGX Yearly Total Debt VS Total AssetsARGX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 30.09 indicates that ARGX is not in any danger for bankruptcy at the moment.
  • ARGX has a better Altman-Z score (30.09) than 92.73% of its industry peers.
  • The Debt to FCF ratio of ARGX is 0.14, which is an excellent value as it means it would take ARGX, only 0.14 years of fcf income to pay off all of its debts.
  • ARGX has a better Debt to FCF ratio (0.14) than 95.41% of its industry peers.
  • ARGX has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • ARGX has a Debt to Equity ratio (0.01) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.14
Altman-Z 30.09
ROIC/WACC0.81
WACC7.43%
ARGX Yearly LT Debt VS Equity VS FCFARGX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

  • A Current Ratio of 5.60 indicates that ARGX has no problem at all paying its short term obligations.
  • With a Current ratio value of 5.60, ARGX perfoms like the industry average, outperforming 58.70% of the companies in the same industry.
  • ARGX has a Quick Ratio of 5.27. This indicates that ARGX is financially healthy and has no problem in meeting its short term obligations.
  • ARGX's Quick ratio of 5.27 is in line compared to the rest of the industry. ARGX outperforms 59.46% of its industry peers.
Industry RankSector Rank
Current Ratio 5.6
Quick Ratio 5.27
ARGX Yearly Current Assets VS Current LiabilitesARGX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • ARGX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1512.50%, which is quite impressive.
  • Looking at the last year, ARGX shows a very strong growth in Revenue. The Revenue has grown by 64.71%.
  • ARGX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 94.61% yearly.
EPS 1Y (TTM)1512.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%272.66%
Revenue 1Y (TTM)64.71%
Revenue growth 3Y63.92%
Revenue growth 5Y94.61%
Sales Q2Q%95.51%

3.2 Future

  • ARGX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 105.80% yearly.
  • Based on estimates for the next years, ARGX will show a very strong growth in Revenue. The Revenue will grow by 35.42% on average per year.
EPS Next Y934.93%
EPS Next 2Y316.29%
EPS Next 3Y180.77%
EPS Next 5Y105.8%
Revenue Next Year95.19%
Revenue Next 2Y63.47%
Revenue Next 3Y48.27%
Revenue Next 5Y35.42%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ARGX Yearly Revenue VS EstimatesARGX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
ARGX Yearly EPS VS EstimatesARGX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 20 40 60 80 100

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 61.57, which means the current valuation is very expensive for ARGX.
  • 90.06% of the companies in the same industry are more expensive than ARGX, based on the Price/Earnings ratio.
  • ARGX is valuated expensively when we compare the Price/Earnings ratio to 27.97, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 25.54, which means the current valuation is very expensive for ARGX.
  • ARGX's Price/Forward Earnings ratio is rather cheap when compared to the industry. ARGX is cheaper than 92.35% of the companies in the same industry.
  • ARGX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.96.
Industry RankSector Rank
PE 61.57
Fwd PE 25.54
ARGX Price Earnings VS Forward Price EarningsARGX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ARGX is valued cheaper than 89.87% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ARGX indicates a rather cheap valuation: ARGX is cheaper than 90.82% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 164.76
EV/EBITDA 93.81
ARGX Per share dataARGX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ARGX's earnings are expected to grow with 180.77% in the coming years.
PEG (NY)0.07
PEG (5Y)N/A
EPS Next 2Y316.29%
EPS Next 3Y180.77%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ARGX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ARGENX SE - ADR

NASDAQ:ARGX (2/13/2026, 8:00:00 PM)

After market: 821.96 0 (0%)

821.96

-11.58 (-1.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-30
Earnings (Next)02-26
Inst Owners43.42%
Inst Owner Change2.77%
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap50.87B
Revenue(TTM)3.60B
Net Income(TTM)1.28B
Analysts84
Price Target1026.93 (24.94%)
Short Float %2.76%
Short Ratio4.97
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)7.11%
Max EPS beat(2)23.2%
EPS beat(4)3
Avg EPS beat(4)3962.36%
Min EPS beat(4)-38.07%
Max EPS beat(4)15857.2%
EPS beat(8)5
Avg EPS beat(8)1996.71%
EPS beat(12)8
Avg EPS beat(12)1343.38%
EPS beat(16)12
Avg EPS beat(16)1012.62%
Revenue beat(2)1
Avg Revenue beat(2)3.68%
Min Revenue beat(2)-0.81%
Max Revenue beat(2)8.17%
Revenue beat(4)3
Avg Revenue beat(4)5.02%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)8.17%
Revenue beat(8)6
Avg Revenue beat(8)5.96%
Revenue beat(12)10
Avg Revenue beat(12)14.45%
Revenue beat(16)13
Avg Revenue beat(16)17.87%
PT rev (1m)5.57%
PT rev (3m)18.5%
EPS NQ rev (1m)-0.25%
EPS NQ rev (3m)-0.25%
EPS NY rev (1m)-0.56%
EPS NY rev (3m)6.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.97%
Valuation
Industry RankSector Rank
PE 61.57
Fwd PE 25.54
P/S 16.67
P/FCF 164.76
P/OCF 125.98
P/B 8.34
P/tB 8.66
EV/EBITDA 93.81
EPS(TTM)13.35
EY1.62%
EPS(NY)32.19
Fwd EY3.92%
FCF(TTM)4.99
FCFY0.61%
OCF(TTM)6.52
OCFY0.79%
SpS49.3
BVpS98.5
TBVpS94.97
PEG (NY)0.07
PEG (5Y)N/A
Graham Number172.01
Profitability
Industry RankSector Rank
ROA 17.84%
ROE 21%
ROCE 7.61%
ROIC 6.01%
ROICexc 16.72%
ROICexgc 18.56%
OM 15.3%
PM (TTM) 41.97%
GM 89.4%
FCFM 10.12%
ROA(3y)-5.23%
ROA(5y)-11.34%
ROE(3y)-5.76%
ROE(5y)-13.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.14
Debt/EBITDA 0.07
Cap/Depr 428.74%
Cap/Sales 3.12%
Interest Coverage 519.07
Cash Conversion 82.6%
Profit Quality 24.11%
Current Ratio 5.6
Quick Ratio 5.27
Altman-Z 30.09
F-Score6
WACC7.43%
ROIC/WACC0.81
Cap/Depr(3y)176.19%
Cap/Depr(5y)545.91%
Cap/Sales(3y)10.66%
Cap/Sales(5y)13.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1512.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%272.66%
EPS Next Y934.93%
EPS Next 2Y316.29%
EPS Next 3Y180.77%
EPS Next 5Y105.8%
Revenue 1Y (TTM)64.71%
Revenue growth 3Y63.92%
Revenue growth 5Y94.61%
Sales Q2Q%95.51%
Revenue Next Year95.19%
Revenue Next 2Y63.47%
Revenue Next 3Y48.27%
Revenue Next 5Y35.42%
EBIT growth 1Y208.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1529.77%
EBIT Next 3Y219.36%
EBIT Next 5Y122.96%
FCF growth 1Y140.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y161.76%
OCF growth 3YN/A
OCF growth 5YN/A

ARGENX SE - ADR / ARGX FAQ

What is the fundamental rating for ARGX stock?

ChartMill assigns a fundamental rating of 6 / 10 to ARGX.


What is the valuation status for ARGX stock?

ChartMill assigns a valuation rating of 6 / 10 to ARGENX SE - ADR (ARGX). This can be considered as Fairly Valued.


Can you provide the profitability details for ARGENX SE - ADR?

ARGENX SE - ADR (ARGX) has a profitability rating of 5 / 10.


What are the PE and PB ratios of ARGENX SE - ADR (ARGX) stock?

The Price/Earnings (PE) ratio for ARGENX SE - ADR (ARGX) is 61.57 and the Price/Book (PB) ratio is 8.34.


What is the earnings growth outlook for ARGENX SE - ADR?

The Earnings per Share (EPS) of ARGENX SE - ADR (ARGX) is expected to grow by 934.93% in the next year.